Oncotype DX for prostate cancer
Jump to navigation
Jump to search
Indications
- assessment of prostate carcinoma
Contraindications
- not appropriate for carcinoma in situ
- not appropriate for metastatic cancer
Specimen
- tissue from prostate biopsy
Procedure
- analyzes 17 genes, presumably expression of 17 genes
Notes
- introduced in 2013
- price (2012) $3800
More general terms
Additional terms
References
- ↑ Physician's First Watch, May 9, 2013 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
Pollack A New Test Improves Assessment of Prostate Cancer Risk, Study Says. New York Times, May 8, 2013 http://www.nytimes.com/2013/05/08/business/prostate-cancer-test-from-genomic-health-assesses-risks.html?_r=0
Marchione M Gene test may help guide prostate cancer treatment. Associated Press. May 8, 2013 http://health.usnews.com/health-news/news/articles/2013/05/08/gene-test-may-help-guide-prostate-cancer-treatment2) Mulcahy N 'Notable Differences' With 3 Prostate Cancer Genomics Tests. Medscape - May 20, 2018. https://www.medscape.com/viewarticle/896937